A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study (Q35034020)
Jump to navigation
Jump to search
scientific article published on October 18, 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study |
scientific article published on October 18, 2011 |
Statements
1 reference
A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study (English)
1 reference
J. E. Ward
T. Karrison
G. Chatta
M. Hussain
D. Shevrin
R. Z. Szmulewitz
P. H. O'Donnell
W. M. Stadler
18 October 2011
1 reference
1 reference
1 reference
15
1 reference
1
1 reference
87-92
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference